Non-invasive embryo genetic screening in egg donation cycles
Official title: Non-invasive Preimplantation Genetic Screening (niPGTA) in Oocyte Donation Patients.
Run by Instituto Bernabeu · NCT07364526 · Data updated 2026-11-12
This will test whether a non-invasive genetic test of the embryo culture fluid can predict implantation and pregnancy outcomes for people receiving donated eggs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 164 (estimated) |
| Sponsor | Instituto Bernabeu Academic / other |
| Locations | 1 site (Alicante) |
| Status | Recruiting |
| Started | February 26, 2026 |
| Main results expected | March 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07364526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are oocyte recipients aged 18–50 planning a single blastocyst transfer with a partner who has normal sperm FISH and who can give informed consent.
✕Probably not a fit
Patients with uterine malformations, abnormal parental karyotypes, or those not undergoing single blastocyst donor transfers (or who cannot consent) are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, blinded, non-selection study in women receiving donor oocytes who undergo single blastocyst transfer. Embryos will be chosen for transfer using standard morphological criteria only, and the spent culture medium will be collected without influencing clinical decisions. Cell-free embryonic DNA in the spent medium will be analyzed by next-generation sequencing to detect chromosomal aneuploidies (niPGTA). The study will compare niPGTA results from transferred embryos that implant or lead to ongoing pregnancy versus those that fail to implant or result in pregnancy loss.
Why it matters
Potential benefit: If successful, this could allow clinicians to identify embryos at higher risk of implantation failure or miscarriage without performing an invasive embryo biopsy.
How similar studies have gone: Other studies of non-invasive PGT‑A have shown mixed results, with some promising concordance but variable reliability, so its clinical value in egg donation cycles remains unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women between 18 and 50 years old who are oocyte recipients. * Signed consent form * Transfer of a single blastocyst-stage embryo * Male with normal sperm FISH Exclusion Criteria: * Uterine malformations * Abnormal karyotypes in either partner * Failure to sign informed consent
Where it's running
-
Instituto Bernabeu
Alicante, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
G-CSF for DOR in women undergoing IVF
This trial tests whether G-CSF shots can improve IVF outcomes for women with diminished ovarian reserve.
-
Dual Trigger vs HCG Trigger for Final Maturation in Normal Responders
In normal responders undergoing ICSI cycles, this study tests whether using a dual trigger (GnRH agonist plus hCG) improves outcomes compared with the standard hCG trigger.
-
Pentoxifylline to improve uterine lining and frozen embryo transfer outcomes
This trial sees if giving pentoxifylline alongside standard estradiol helps women with good-quality day‑5 frozen embryos get a thicker uterine lining and better frozen embryo transfer success.
-
Tadalafil to increase uterine lining and improve frozen embryo transfer success
This test sees if adding daily tadalafil to standard estrogen helps women with unexplained infertility using good-quality day‑5 frozen embryos get a thicker uterine lining and better transfer outcomes.
-
Aromatherapy to support mental health in women undergoing IVF
This will test whether inhaling lavender oil twice daily can reduce anxiety, stress, and depression and improve quality of life for women awaiting IVF.
-
Single-step versus multi-step blastocyst warming for frozen embryo transfer
This tests whether a simpler single-step thawing solution works as well or better than the standard multi-step warming for women having frozen blastocyst transfers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.